Clinical Trial Update: Study of Ticilimumab in Patients With Metastatic Colorectal Cancer Whose Disease Had Progressed After Treatment [Phase 2]

View source ↗

Summary

An update on a Phase 2 trial of ticilimumab for metastatic colorectal cancer that progressed after prior treatment, with the study status marked as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Ticilimumab (ticilimumab)

Snippet

Sponsor: AstraZeneca | Conditions: Colorectal Neoplasms | Phase 2 | Status: COMPLETED